21 January 2025
Health Care Law Today
DEA Unveils Long-Overdue Special Registration for Telemedicine in Proposed Rule
In the final days of the Biden administration, the DEA released a proposed rule that would allow practitioners with a Special Registration to prescribe Schedule III-V, and in limited circumstances Schedule II, controlled substances via telemedicine.
